The Vdr: Why Your Vitamin D3 Might Not Be Protecting Your Ageing Brain
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Vitamin D3 plays multiple roles in brain health. It influences how your brain produces serotonin (the chemical targeted by antidepressant medications), reduces inflammation in the brain, supports the growth of new brain connections, and protects against cellular damage. Studies consistently show that people with low vitamin D levels report more depression and anxiety than those with adequate levels.
However, the research tells a nuanced story. Large studies testing whether vitamin D prevents depression in generally healthy people found no effect. But smaller studies focusing on people who are actually deficient in vitamin D show real mood improvements, with depression scores dropping by measurable amounts after 12 weeks of supplementation at 2,000 IU per day or more. The difference appears to be that vitamin D’s mood benefits matter most for people whose levels are genuinely low.
Vitamin D deficiency is extremely common in the UK, particularly through autumn and winter. Supplementation at 1,000 to 2,000 IU daily is safe with virtually no risk of harm at these doses. If your mood has been persistently low and you spend little time outdoors, getting your vitamin D levels checked is a reasonable step.
Verdict: Vitamin D3 is not a cure for depression, but if you are deficient, supplementation may meaningfully improve mood through multiple brain mechanisms, and the safety profile makes it worth considering as part of a broader approach to mental health.
What if one of the most common nutrient deficiencies in the UK is quietly making millions of people feel worse than they need to? Not dramatically depressed, necessarily, but flatter, more anxious, less resilient to stress, slower to recover from a bad week. What if the answer isn’t just about bones and sunshine, but about how your brain makes serotonin, manages inflammation, and literally grows new connections?
Vitamin D3’s relationship with mood is one of the most debated topics in nutritional psychiatry right now. The research is genuinely fascinating, and genuinely complicated. There are large trials showing no effect. There are smaller trials and mechanistic studies showing real, meaningful benefits. And there’s a growing body of work on *how* vitamin D3 influences the brain that makes the whole story a lot more interesting than a simple “yes it works” or “no it doesn’t.”
At Vitacuity, we’ve analysed over 1.77 million research papers, selecting the most relevant to help you understand what the science actually says. Here’s the honest, complete picture.
Most people know vitamin D3 as the “sunshine vitamin”, the nutrient your skin makes when exposed to UV light, and which keeps your bones strong. But it’s far more than a bone mineral. In its active form, called 1,25-dihydroxyvitamin D3 (or calcitriol), vitamin D3 behaves more like a hormone than a vitamin, interacting with receptors throughout the body, including deep inside the brain [5].
Vitamin D receptors (known as VDRs) are found throughout the central nervous system, including in regions directly involved in mood regulation, stress response, and memory [8]. This isn’t a side note, it’s a fundamental clue. Your brain isn’t just passively receiving vitamin D; it has specific receptors *designed* to respond to it.
So what does vitamin D3 actually do in the brain? Several mechanisms have been identified [5][8][11]:
It influences serotonin production. The active form of vitamin D3 regulates the gene for tryptophan hydroxylase 2 (TPH2), which is the enzyme your brain uses to *make* serotonin in the first place. It also influences serotonin reuptake transporters (SERT) and the enzyme that breaks serotonin down (MAO-A) [10]. In plain English: vitamin D3 appears to act on the same biochemical pathway that antidepressant medications (SSRIs) target, but upstream, influencing how much serotonin your brain produces and retains, rather than just slowing its breakdown [3].
It modulates neuroinflammation. Chronic low-grade inflammation in the brain, called neuroinflammation, is increasingly understood as a major driver of depression and cognitive decline. Vitamin D3 acts on glial cells (the brain’s immune cells, including astrocytes and microglia) to reduce pro-inflammatory cytokines and support antioxidant defences [11]. When these inflammatory pathways run unchecked, the result can include persistent low mood, fatigue, and impaired cognitive function.
It supports BDNF, your brain’s growth factor. Brain-derived neurotrophic factor (BDNF) is sometimes described as “fertiliser for the brain.” It supports the survival of existing neurons, promotes the growth of new connections, and is critically involved in learning, memory, and mood regulation. Vitamin D3 appears to support BDNF production, particularly in the hippocampus, a brain region central to both memory and emotional regulation [4].
It protects against oxidative stress. The brain is metabolically intense and particularly vulnerable to oxidative damage. Vitamin D3 supports the formation of antioxidants, lowers oxidative stress, and appears to support mitochondrial health in brain cells [5].
This is not a simple mechanism. Vitamin D3 doesn’t just tweak one knob. It appears to influence multiple intersecting systems, serotonin, inflammation, neuroplasticity, and cellular protection, all of which are implicated in how we feel, think, and age.
The relationship between low vitamin D levels and depression has been studied extensively. A 2025 systematic review, one of the most comprehensive to date, reviewed 8,052 potentially eligible papers, ultimately including 66 studies after rigorous screening [1]. The overall finding: there is a consistent association between low vitamin D serum levels and depression, particularly in cross-sectional research (studies examining people at a single point in time).
A 2022 review of the evidence reinforces this, concluding that “low vitamin D levels are associated with increased symptoms of depression and anxiety” [13]. A 2021 review similarly identified vitamin D deficiency as a recurring feature among people with depression, bipolar disorder, obsessive-compulsive disorder, and psychosis, and suggested that supplementation might act as a natural adjunct to psychiatric treatment or help boost response to medication in resistant cases [8].
Evidence grade: Promising to strong for association. The consistent cross-sectional data across dozens of studies is notable. Causality is less certain, more on that below.
One of the more striking findings in recent literature concerns how vitamin D3 might intersect with the same biochemical system that SSRIs target. A 2025 literature review examined whether vitamin D’s effect on serotonin synthesis might reduce the need for SSRI medication [3]. The review found evidence that vitamin D increases the amount of serotonin available in the synaptic gap, the space between neurons where serotonin signals are transmitted, through its regulation of TPH2 gene expression and influence on serotonin reuptake transporters [3][10].
The review also found that vitamin D supplementation *in conjunction with* SSRI medication appeared to produce an additive effect, meaning patients taking both seemed to do better than those taking SSRIs alone [3]. This is preliminary evidence and shouldn’t be taken as a reason to change medication without medical guidance, but it’s a meaningful finding that warrants further investigation.
Evidence grade: Promising. Mechanistic evidence is strong; clinical trial evidence is early-stage and mostly based on review-level findings rather than large independent RCTs.
A 2025 structured narrative review examined 13 studies looking at vitamin D, BDNF, and mood or cognitive outcomes [4]. The findings are worth looking at closely:
– Supplementation of at least 2,000 IU/day for 12 weeks reduced scores on the Beck Depression Inventory (BDI, a validated mood scale) by 1.7 to 7.6 points, and increased BDNF levels by approximately 7% [4]. – Each 1 ng/mL increase in circulating vitamin D (measured as 25(OH)D) decreased the likelihood of depressive symptoms, particularly when BDNF levels were already higher [4]. – Each 10 ng/mL increase in 25(OH)D was associated with a 0.6-point improvement in MMSE scores (a standard cognitive assessment tool) and a 15% increase in serum BDNF [4]. – In animal studies, vitamin D increased hippocampal BDNF and reversed stress-induced depressive behaviours [4][12].
The review concluded that vitamin D supplementation may support mood and cognition via BDNF modulation, particularly in people with insufficient vitamin D levels (below 30 ng/mL, which is a threshold a significant proportion of UK adults fall below, especially in winter) [4].
Evidence grade: Promising. Human data on BDNF and mood is meaningful, though studies remain relatively small and short in duration. Animal data is supportive.
The neuroinflammation angle deserves its own section because it reframes how we think about depression entirely. Depression has historically been explained primarily through the “serotonin deficit” model, the idea that depressed brains simply have too little serotonin. But more recent research points to chronic neuroinflammation as an equally, perhaps more, important driver [8][11].
A comprehensive 2024 review found that vitamin D3, acting through VDRs in astrocytes and microglia (the brain’s immune cells), may modulate the production of pro-inflammatory cytokines and support antioxidant defences [11]. When these inflammatory cascades run unchecked, as they do in chronic stress, poor sleep, sedentary lifestyles, or simply low vitamin D status, the result can include persistent low mood, fatigue, difficulty concentrating, and reduced resilience.
The review also noted that vitamin D deficiency has been identified as a common thread in the increased risk of multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and depression [11], suggesting that vitamin D’s neuroprotective role extends far beyond mood alone.
Evidence grade: Promising for the neuroinflammation-depression link; early-stage for supplementation as a direct intervention for neuroinflammatory conditions.
A particularly interesting study from 2014 examined 355 depressed older adults and 124 non-depressed comparison subjects, all aged 60 or over [14]. It measured two forms of vitamin D: the common storage form (25-OH vitamin D3) and the *biologically active* form (1,25-(OH)₂ vitamin D3).
The finding: depressed patients had significantly lower levels of *both* forms compared to non-depressed subjects. But the difference was largest for the biologically active form, with a Cohen’s d of 0.48, a moderate effect size that’s clinically meaningful [14]. The researchers also found that tricyclic antidepressants (TCAs) were specifically correlated with lower levels of the active form of vitamin D, suggesting these medications may interfere with vitamin D metabolism, a finding with potential implications for how depression is treated in older adults [14].
Evidence grade: Promising. This is observational data (not a trial), but the sample size (479 participants total) and the distinction between active and inactive vitamin D forms adds nuance that is often missing from simpler studies.
Honesty is part of how we work at Vitacuity, so we need to talk about the VITAL-DEP trial, published in *JAMA* in 2020 [7].
This was a genuinely large, well-designed study. Over 18,000 adults aged 50 and over were randomised to either 2,000 IU/day of vitamin D3 or placebo, followed for a median of 5.3 years. The primary outcome was incidence or recurrence of clinically significant depression. The result: no significant difference between the vitamin D3 group and the placebo group. Hazard ratio of 0.97, with the confidence interval clearly crossing 1 [7].
This is an important finding and shouldn’t be dismissed. It suggests that supplementing vitamin D3 at 2,000 IU/day does not *prevent* depression in a general population of adults who are mostly *not* deficient at the outset.
But here’s the nuance: the VITAL-DEP trial did not select for participants with low vitamin D levels. The mean age was 67.5 years and participants were not screened for vitamin D insufficiency at baseline. Multiple other studies, including the BDNF review discussed above [4], suggest that vitamin D’s mood benefits are most pronounced when baseline levels are low (below 30 ng/mL). Supplementing people who are already replete may simply not move the needle.
A separate randomised controlled trial from 2019 (the D3-vit-dep study) similarly found no significant reduction in Hamilton Depression Scale scores after vitamin D supplementation in depressed patients [9], though notably, baseline vitamin D status varied considerably across participants, and the sample size was small.
Evidence grade: Conflicted. Large null trials exist alongside smaller positive ones. The most coherent explanation of the discrepancy: vitamin D’s antidepressant potential appears most relevant in those with genuine insufficiency or deficiency, not in replete populations.
Here’s where we have to be genuinely honest, because this is where the research has real gaps.
We don’t know if supplementation *prevents* depression in the general population. The largest, longest trial, VITAL-DEP with over 18,000 participants, found no preventive effect [7]. That’s a significant finding. The association between low vitamin D and depression is robust, but association is not causation. It’s possible that depression itself causes people to spend less time outdoors and eat less well, *causing* low vitamin D, rather than the other way around.
We don’t know the optimal dose for mood. The BDNF review found benefits at 2,000 IU/day or more for at least 12 weeks [4], but the VITAL-DEP trial used the same dose and found no effect [7]. The difference may come down to baseline vitamin D status, population characteristics, or outcome measures.
Most studies are cross-sectional, not longitudinal. The 2025 systematic review noted that while cross-sectional studies consistently show the association between low vitamin D and depression, very few longitudinal studies have demonstrated that low vitamin D *predicts* the later development of depressive symptoms, which is the stronger causal claim [1].
The BDNF mechanism is compelling but not yet clinically proven. Animal studies showing vitamin D increases hippocampal BDNF are consistent and interesting [4][12]. Human data on BDNF as a mediator of vitamin D’s mood effects is growing but still relatively small-scale.
We don’t fully understand the interaction with antidepressant medications. The 2025 serotonin review found promising signals for vitamin D as an adjunct to SSRIs [3], and the 2014 late-life depression study found that tricyclic antidepressants specifically lowered active vitamin D levels [14]. These interactions are real but not yet well characterised.
Long-term, adequately powered trials with objective tools are still needed, particularly in populations selected for vitamin D insufficiency [4].
Here’s what a sensible, informed person would do with this information.
Vitamin D3 deficiency is genuinely common, especially in the UK, where latitude, indoor lifestyles, and seasonal variation mean that a significant proportion of adults spend months of the year with suboptimal levels. The research does not support the claim that vitamin D3 is a cure for depression or that supplementing will lift low mood in someone who is already replete. The VITAL-DEP trial is clear on that [7].
But the picture looks different if you’re actually deficient or insufficient. The mechanistic evidence, serotonin synthesis, neuroinflammation, BDNF, is compelling and consistent [3][4][10][11]. The BDNF review found real, measurable mood improvements (BDI reductions of 1.7–7.6 points) and a 7% increase in BDNF at 2,000 IU/day over 12 weeks, specifically in people with low baseline levels [4]. The association between low vitamin D and depression across 66 studies is not something to wave away [1].
And here’s the practical logic: vitamin D3 is extraordinarily safe at normal supplementation doses. Toxicity requires sustained mega-doses, deficiency is vastly more common and harmful than excess. In the UK, the NHS recommends 400 IU/day as a baseline for everyone in autumn and winter; many researchers argue that 1,000–2,000 IU/day is a more meaningful target for adults concerned about mood and cognitive health. At these doses, the risk-benefit calculation is simple: the downside is negligible, and if you’re among the substantial proportion of UK adults who are deficient, the potential upside is real.
Practically speaking:
– Supplement daily through autumn and winter. 1,000–2,000 IU of vitamin D3 is a safe, evidence-informed daily dose for UK adults. Excess vitamin D is not readily excreted like water-soluble vitamins, it’s fat-soluble, but toxicity at these doses is not a realistic concern. Far more adults are deficient than are at risk from supplementing at this level. – Get outdoors when you can. Natural synthesis from sun exposure is still the most efficient route to adequate vitamin D, but for much of the year in the UK, supplementation is the practical necessity. – If you’re already taking antidepressants, the early evidence suggests vitamin D may act as a useful adjunct, particularly if your levels are low [3]. This is a conversation worth having with your GP, particularly in light of the 2014 finding that tricyclic antidepressants may specifically lower active vitamin D levels [14]. – Don’t expect miracles from supplementation alone. Vitamin D3 is one piece of a larger puzzle. Sleep, exercise, social connection, and diet all matter enormously for mood. Think of adequate vitamin D as *removing a barrier* to feeling well, not as a treatment in its own right. – If your mood has been consistently low and you haven’t had your vitamin D levels checked, it’s a reasonable and low-cost thing to explore, especially if you’re over 40, spend little time outdoors, or live in the north of England or Scotland.
The bottom line: vitamin D3 is not a magic bullet for depression. But the evidence that it plays a meaningful role in brain health, through serotonin, neuroinflammation, and BDNF, is serious enough to take seriously. Deficiency is common, supplementation is safe, and the stakes of staying deficient are higher than the stakes of supplementing sensibly.
[1] Vitamin D and depression in adults: A systematic review. (2025). DOI: 10.17305/bb.2025.12331 | https://pubmed.ncbi.nlm.nih.gov/40322928/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451993/
[2] The Role of Vitamin D in the Management of Major Depressive Disorder: A Systematic Review. (2025). DOI: 10.3390/ph18060792 | https://pubmed.ncbi.nlm.nih.gov/40573189/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12196374/
[3] Can Vitamin D Reduce the Need for SSRI by Modulating Serotonin Synthesis?: A Review of Recent Literature. (2025). DOI: 10.1007/s13668-025-00630-7 | https://pubmed.ncbi.nlm.nih.gov/40025236/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872774/
[4] Impact of Vitamin D Status and Supplementation on Brain-Derived Neurotrophic Factor and Mood-Cognitive Outcomes: A Structured Narrative Review. (2025). DOI: 10.3390/nu17162655 | https://pubmed.ncbi.nlm.nih.gov/40871684/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12389325/
[5] Vitamin D and Brain Health. (2026). DOI: 10.1007/978-3-032-04357-3_5 | https://pubmed.ncbi.nlm.nih.gov/41219598/
[6] The effect of vitamin D3 deficiency on the severity of depressive symptoms. Overview of current research. (2017). https://pubmed.ncbi.nlm.nih.gov/28866715/
[7] Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. (2020). *JAMA*. DOI: 10.1001/jama.2020.10224 | https://pubmed.ncbi.nlm.nih.gov/32749491/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403921/
[8] Vitamin D: A Pleiotropic Hormone with Possible Psychotropic Activities. (2021). DOI: 10.2174/0929867328666201210104701 | https://pubmed.ncbi.nlm.nih.gov/33302828/
[9] Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep). (2019). DOI: 10.1186/s13104-019-4218-z | https://pubmed.ncbi.nlm.nih.gov/30944021/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446320/
[10] Vitamin D, Depressive Symptoms, and Covid-19 Pandemic. (2021). DOI: 10.3389/fnins.2021.670879 | https://pubmed.ncbi.nlm.nih.gov/34054418/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155626/
[11] Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. (2024). DOI: 10.2174/0113816128281314231219113942 | https://pubmed.ncbi.nlm.nih.gov/38303529/
[12] Effects of Vitamin D. (2019). DOI: 10.3390/nu11081726 | https://pubmed.ncbi.nlm.nih.gov/31357443/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723744/
[13] Is Vitamin D Important in Anxiety or Depression? What Is the Truth? (2022). DOI: 10.1007/s13668-022-00441-0 | https://pubmed.ncbi.nlm.nih.gov/36097104/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468237/
[14] Antidepressants differentially related to 1,25-(OH)₂ vitamin D₃ and 25-(OH) vitamin D₃ in late-life depression. (2014). https://pubmed.ncbi.nlm.nih.gov/24736799/
[15] The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials. (2023). DOI: 10.1080/10408398.2022.2096560 | https://pubmed.ncbi.nlm.nih.gov/35816192/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
Quick Read Multiple large studies show that people who drink coffee regularly have lower rates of dementia and cognitive decline.
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.